This study reveals the mechanism by which MALAT1 acts as a promoter of HCC, possibly by inhibiting miR-140. Therefore, targeting MALAT1 or miR-140 may help slow the progression of HCC. The gene discussed is MALAT1; the disease is hepatocellular carcinoma.